首页> 美国卫生研究院文献>British Heart Journal >Outcome of isolated congenital complete heart block diagnosed in utero.
【2h】

Outcome of isolated congenital complete heart block diagnosed in utero.

机译:在子宫内诊断出孤立的先天性完全性心脏传导阻滞的结果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: To establish identifiable prenatal factors in fetal heart block which might predict death in utero, the need for intervention, or the probability of pacemaker requirement. SETTING: Tertiary referral unit for fetal echocardiography. SUBJECTS: 36 fetuses with congenital complete heart block and structurally normal hearts identified between 1980 and 1993. METHODS: Maternal anti-Ro antibody status was documented. Prenatal variables examined included absolute heart (ventricular) rate, change in rate, and development of hydrops fetalis. Postnatally, heart rate, need for pacing, and the indications for pacing were detailed. RESULTS: Of the total of 36 patients, there are 24 survivors; 11 are paced. Of those fetuses which died, two were electively aborted for severe hydrops, seven died in utero, two were immediate postnatal deaths, and one was an unrelated infant death. The trend was for the heart rate to decrease during fetal life and postnatally. Fetuses with deteriorating cardiac function did not always show the lowest heart rates. Bradycardia of less than 55 beats/min in early pregnancy or rapid decrease in heart rate prenatally were poor prognostic signs. Hydrops was also associated with bad outcome, 10 out of the 12 hydropic fetuses dying (83%). Of 10 fetuses presenting with a heart rate above 60/min, nine survived of whom three required pacing. Of seven presenting with heart rates of 50/min or less, only three survived and two of these required pacing. Of the two fetuses with negative maternal anti-Ro antibody status one died in utero and one required heart transplantation after pacemaker insertion. CONCLUSIONS: Isolated complete heart block identified in fetal life does not always have a good prognosis. An individual heart rate does not accurately predict the outcome in utero or the need for postnatal pacing. Regular, careful monitoring during pregnancy is required in order to optimise care and timing of any interventions.
机译:目的:在胎儿心脏传导阻滞中建立可识别的产前因素,这些因素可以预测子宫内死亡,需要干预或需要起搏器的可能性。地点:胎儿超声心动图的三级转诊单位。研究对象:1980年至1993年间鉴定出的36例先天性完全性心脏阻滞和心脏结构正常的胎儿。方法:记录母体抗Ro抗体状态。检查的产前变量包括绝对心脏(心室)率,变化率和胎儿积水的发展。出生后,详细记录了心率,起搏需求以及起搏适应症。结果:在36名患者中,有24名幸存者。 11个节奏。在那些死亡的胎儿中,有两个因严重的积水而被选择性流产,有七个在子宫内死亡,两个是出生后立即死亡,一个是与婴儿无关的死亡。趋势是在胎儿生命中和出生后心率下降。心脏功能恶化的胎儿并非总是表现出最低的心率。妊娠早期心动过缓低于55次/分钟或产前心率快速下降是不良的预后体征。积液还与不良预后相关,在12个积水胎儿中有10个死亡(83%)。心率高于60 / min的10名胎儿中,有9名幸存下来,其中3名需要起搏。在有7个心律不超过50 / min的患者中,只有3个幸存,其中2个需要起搏。母体抗Ro抗体状态为阴性的两名胎儿在子宫内死亡,并且在植入起搏器后需要进行心脏移植。结论:在胎儿生命中发现的孤立的完全性心脏传导阻滞并不总是具有良好的预后。个人心率不能准确预测子宫内的结局或产后起搏的需要。怀孕期间需要定期仔细监测,以优化护理和任何干预措施的时机。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号